Acadia Pharmaceuticals, Inc. (ACAD) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 19.74 -0.57 (2.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.31 | 52 Week High | $42.49 | |||
| Open | $20.22 | 52 Week Low | $16.64 | |||
| Day High | $20.25 | P/E | N/A | |||
| Day Low | $19.58 | EPS | $-0.42 | |||
| Volume | 260,286 | |||||
